Lycopene.
Research-backed compound with potential health benefits. Lycopene is the red pigment from tomatoes. It's a fat-soluble antioxidant that rides in your LDL particles and settles into skin and prostate tissue, supporting normal antioxidant defence.
Reviewed March 2026
- Category
- Compound
What Lycopene is, and what it does.
- Does it work
- Suits people who rarely eat cooked tomato, and anyone thinking about skin resilience through a sunny season. Eat tomato sauce most weeks and you're already getting a steady supply.
- How much to take
- Start with 6mg to 15mg a day, the daily maintenance band, with a meal that has fat in it. The 30mg used in trials is a research condition rather than a daily target.
- Time to feel it
- About 12 weeks of daily use.
- The first dose
- Day one is quiet. Absorption starts within hours when you take it with fat, and it's the tissue build-up over the following weeks that the research tracks.
- With regular use
- Over two to three months plasma and tissue levels plateau, and what shifts are readings like oxidised LDL and skin redness thresholds rather than anything you would feel.
- How well tolerated
- Well tolerated. Check with your doctor if you're pregnant or on medication.
- How it feels
- No sensation attached to it. This one lands on lab measures like oxidised LDL and skin redness thresholds rather than on how your day goes.
- The overlooked benefit
- Cooking tomatoes in oil shifts the molecule into cis forms your gut takes up more readily, so tomato paste delivers more lycopene than the same weight of fresh fruit.
6 to 15mg a day is where Lycopene works.
Source: Cheng et al. 2019 Medicine meta-analysis; Ried & Fakler 2011 Maturitas
In a randomised controlled trial in 75 healthy adults, daily tomato juice providing 15.0 or 26.7 mg of lycopene raised serum lycopene concentrations and, at week 12 of daily intake with measurements every 4 weeks, flow-mediated dilation, a measure of normal vascular endothelial function, was higher than with a low-lycopene placebo juice.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Lycopene is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- blood pressure already in the normal rangeMeta-analysis
- cholesterol already in the normal rangeMeta-analysis
- markers of oxidative stress in plasmaRandomised trial
- skin resilience through sun exposureRandomised trial
- prostate comfort in later yearsCohort study
- endothelial functionRandomised trial
- sperm quality measures in menRandomised trial
Questions people ask about Lycopene.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Both carotenoids incorporate into the same mixed micelles and use the same intestinal scavenger receptor route. Large doses of one lower absorption of the other when taken in the same meal.
Lutein and lycopene compete for space in mixed micelles and for the SR-B1 uptake pathway. Co-dosing at high amounts reduces the blood response to either one.
Zeaxanthin shares the same lipid micelle and transporter route as lycopene. High simultaneous doses split the available carrier capacity.
Astaxanthin is another lipophilic carotenoid partitioning into the same micelles. Very high single doses can lower the uptake of co-ingested lycopene.
Plant sterols compete with lipophilic compounds for micellar solubilisation in the small intestine. Regular sterol intake lowers circulating carotenoid levels including lycopene.
Soluble viscous fibre thickens the intestinal contents and interferes with micelle formation and diffusion to the brush border. Carotenoid absorption falls when pectin is taken in the same meal.
Psyllium forms a gel that slows lipid emulsification and micelle transfer. Fat-soluble pigments such as lycopene are absorbed less well alongside it.
Lycopene needs co-ingested long-chain fat to form the mixed micelles that carry it across the intestinal wall. Taking it with an oil raises the amount that reaches the blood.
Phospholipids emulsify carotenoid crystals and help them disperse into micelles. Lecithin is used in formulation for exactly this reason.
Lycopene quenches singlet oxygen while tocopherol intercepts lipid peroxyl radicals in the same membrane phase. Each spares the other from being consumed first.
Ascorbate in the aqueous phase can reduce carotenoid radical cations back to the parent pigment at the membrane surface. This recycles part of the lycopene pool during oxidative load.
Phytofluene and its colourless relatives travel with lycopene in the tomato matrix and share the same lipoprotein carriers. They absorb light in a different band, so the mixture covers a wider range than lycopene alone.
Lycopene has no polar groups at all and will not enter mixed micelles without dietary fat present in the same meal. A lipid fill or a few grams of oil at the same time is what moves it from the food matrix into the enterocyte. This is the single largest determinant of how much of a dose is absorbed.
Pancreatic lipase must free fatty acids and monoglycerides before bile salts can assemble the mixed micelles that carry carotenoids. Where lipolysis is incomplete, carotenoid uptake drops even when fat is present. The relationship is a step-dependency, not an additive effect.
Bile salts are what solubilise carotenoids into micelles at the brush border. Reduced bile flow lowers absorption of every fat-soluble compound, lycopene included. This is textbook lipid handling applied to a carotenoid.
Phospholipids reduce particle size in the oil phase and stabilise the emulsion that reaches the small intestine. Carotenoid formulations use them for that reason, alongside beadlet technologies. The effect is on delivery, not on what lycopene does once absorbed.
Biliary phosphatidylcholine is a natural component of the mixed micelle, and added phospholipid contributes to the same structure. It also protects the carotenoid from oxidation within the fill. Formulators use it as both an emulsifier and a stabiliser.
Viscous fibre raises the thickness of the intestinal contents and traps lipid droplets, lowering how much carotenoid reaches the brush border. The effect applies to fat-soluble vitamins in the same way. Timing the fibre away from the carotenoid dose avoids it.
Guar gum forms a viscous layer that slows lipid emulsification and reduces carotenoid transfer into micelles. The interaction is physical and dose-dependent rather than chemical. It is a timing consideration in fibre-plus-carotenoid formulas.
Carotenoids enter the enterocyte partly through SR-B1 and leave packaged in chylomicrons, routes shared with retinyl esters. High doses of one fat-soluble species can reduce apparent uptake of another taken at the same time. Unlike beta-carotene, lycopene has no provitamin A activity of its own.
Selenium is the catalytic centre of glutathione peroxidases, which reduce lipid peroxides, while lycopene quenches singlet oxygen in the membrane before peroxidation starts. The two act at different points of the same lipid-oxidation sequence. A post-hoc analysis of a study in men reported the combination alongside its endpoints, which is supportive rather than confirmatory.
Ubiquinol regenerates alpha-tocopheroxyl radicals inside the lipid bilayer and terminates peroxidation chains. Lycopene works upstream by deactivating singlet oxygen. Both need the same fat-containing meal to be absorbed, which is why they share a softgel well.
Glutathione is the aqueous-phase thiol buffer and lycopene works in the lipid phase, so each covers a compartment the other cannot reach. Animal studies of lycopene routinely report higher tissue glutathione and lower malondialdehyde. Those are oxidative-stress markers, not clinical endpoints.
Alpha-lipoic acid is active in both aqueous and lipid environments and helps regenerate ascorbate and glutathione. Lycopene sits deep in the membrane where it quenches singlet oxygen. Together they cover a wider slice of the antioxidant network than either alone.
Quercetin donates hydrogen atoms at the lipid-water interface and chelates transition metals that would otherwise initiate peroxidation of the carotenoid itself. Formulators use polyphenols partly to protect carotenoids in the fill. The physiological side of the pairing has not been measured for this pair here.
EGCG works at the interface between water and lipid and can spare fat-soluble antioxidants from oxidation. Lycopene degrades readily on exposure to oxygen and light, which is what the catechin addresses in the product. Read this as chemistry within the formulation rather than a demonstrated combination effect in people.
Cold-water-dispersible lycopene beadlets are built by embedding the carotenoid in a starch or gelatin matrix with an antioxidant. The matrix keeps oxygen away and lets a fat-soluble pigment go into a water-based product. This is a delivery technology, not a nutritional pairing.
Nothing specific on file for Lycopene. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Lycopene actually does.
Lycopene is a long carotene with eleven linked double bonds plus two others and no oxygen at all, so it has no water-friendly groups and basically will not dissolve in water.
That long chain of linked double bonds is what lets lycopene soak up the energy of singlet oxygen and shed it as heat, coming back out unchanged.
Lycopene has no beta-ionone ring, so it gives you no vitamin A activity. Your body cannot cut it into retinal the way it can with beta-carotene.
To absorb it you need fat in the meal, plus bile salts and pancreatic lipase to build mixed micelles. A gut wall transporter called SR-B1 helps it in, and it then leaves the gut cell packed into chylomicrons.
Where Lycopene comes from.
It comes from one of three places: tomato skins left over from paste making, a fungus grown in a tank, or a chemical synthesis that builds the same molecule from scratch. Whichever the source, the pigment is pulled out, crystallised clean, measured, and then either suspended in oil for a softgel or dried into granules for a tablet.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Three commercial routes coexist. Tomato skins and pomace from paste production feed the natural extract, Blakeslea trispora cultures feed the fermentation route, and simple isoprenoid building blocks feed chemical synthesis.
In tomato and in Blakeslea the molecule is built through the isoprenoid pathway from phytoene via desaturation steps. In the synthetic route the polyene chain is assembled by Wittig condensation of C15 and C10 fragments to the all-trans product.
Tomato material is extracted with ethyl acetate, hexane or supercritical CO2; fermentation biomass is broken and extracted with solvent after the culture is harvested.
Solvent is removed under vacuum and the carotenoid is crystallised, which raises purity and removes lipids, chlorophylls and residual solvent.
Content is assayed against a lycopene reference and the trans-to-cis ratio is recorded, since isomer distribution differs between routes and affects dispersion behaviour.
The concentrate is standardised into an oleoresin, suspended in oil with tocopherol for softgels, or spray-dried into a starch-matrix beadlet for dry dosage forms.
Labels often say lycopene without naming the route, and the trans-to-cis isomer ratio, which affects how readily it disperses, is rarely stated at all.
Getting Lycopene from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across 11 randomised trials in adults with excess body weight, tomato or tomato-derived lycopene intake was associated with a waist circumference about 1.15 cm smaller, with no consistent change in body weight or BMI.Meta-analysis. Sani et al., 2026 (Food & function). PMID 42300210 ↗
- Pooling 4 clinical studies in 151 men, lycopene supplementation raised sperm concentration (standardised mean difference 0.33) and nonprogressive motility (0.45), with no detectable difference in total motility, morphology, semen volume or DNA damage.Meta-analysis. Viña et al., 2025 (International journal of molecular sciences). PMID 40806357 ↗
- In 8 pooled observational datasets covering 9,131 adults, higher circulating lycopene was associated with less thickening of the carotid artery wall (odds ratio 0.70); observational data can show an association, not a cause.Meta-analysis. Cavero-Redondo et al., 2026 (Nutrients). PMID 41978094 ↗
- Across 7 trials, lycopene showed no detectable overall change in serum IGF-1 (-6.74 ng/mL, confidence interval crossing zero); lower IGF-1 appeared only in subgroups taking 15 mg a day or more and in adults aged 60 and over.Meta-analysis. Xie et al., 2021 (Complementary therapies in medicine). PMID 33259908 ↗
- Pooling randomised studies, lycopene supplementation was examined against circulating IGF-1 and IGF binding protein concentrations; these are blood markers rather than clinical outcomes.Systematic review. Meshkini F et al., 2022 (Phytotherapy Research). PMID 35192223 ↗
- A systematic review of clinical and preclinical work reported associations between lycopene intake and bone tissue markers, with the clinical evidence described as limited relative to the animal data.Systematic review. Silva ANA et al., 2025 (Pharmaceuticals). PMID 40872563 ↗
- In a prospective cohort of adult men, higher dietary lycopene intake was associated with a lower rate of the study's primary endpoint; an observational association, not a demonstrated cause.Cohort study. Lopez-Solis R et al., 2025 (BMC Medicine). PMID 41214650 ↗
- A post-hoc analysis of a randomised study reported fewer incident cases of the primary endpoint among men taking combined selenium and lycopene; post-hoc analyses generate hypotheses rather than settle them.Randomised trial. Morgia G et al., 2017 (Phytomedicine). PMID 28899491 ↗
- A non-invasive immunofluorescence assay on skin smears tracked lycopene status during supplementation, offering a way to confirm exposure without a blood draw.Open-label trial. Petyaev IM et al., 2018 (Monoclonal Antibodies in Immunodiagnosis and Immunotherapy). PMID 29901405 ↗
- Adults undergoing non-surgical dental cleaning who also took systemic lycopene showed changes in the recorded gum-tissue measures compared with cleaning alone.Open-label trial. Rashidi Maybodi F et al., 2025 (BDJ Open). PMID 40670371 ↗
- Lycopene supplementation did not produce a detectable change in productive performance while lowering egg yolk cholesterol and altering related gene expression; the performance result is a failure to detect a difference, not evidence that none exists.Animal study. Orhan C et al., 2021 (British Poultry Science). PMID 33085516 ↗
- Dietary lycopene shifted the hepatic gene expression profile related to fat metabolism in breeding hens.Animal study. Tian H et al., 2020 (Journal of Animal Physiology and Animal Nutrition). PMID 32170789 ↗
- In heat-stressed goats, lycopene supplementation was associated with improved oxidative-balance markers, altered heat-shock protein expression and changes in the lipid profile.Animal study. Verma AK et al., 2026 (International Journal of Biometeorology). PMID 42402074 ↗
- Lycopene given during pregnancy and lactation reduced hepatic damage markers in rodents exposed to thermally oxidised cooking oil.Animal study. Jusuf AA et al., 2026 (Toxicology Reports). PMID 42317611 ↗
- In a rabbit model of acute lung injury, lycopene supplementation lowered inflammatory markers, histopathological scores and DNA damage indices.Animal study. Fioretto JR et al., 2025 (Critical Care Science). PMID 39879436 ↗
- In a rodent parasitic infection model, lycopene supplementation was associated with longer survival and lower parasite burden compared with control animals.Animal study. Varela ELP et al., 2024 (Anais da Academia Brasileira de Ciencias). PMID 39046019 ↗
- Lycopene supplementation altered lipid profile, blood glucose and electrolyte measures in a thioacetamide-induced rodent model.Animal study. Zaidi SNF et al., 2023 (Pakistan Journal of Pharmaceutical Sciences). PMID 37599493 ↗
- Dietary lycopene changed oxidative-stress markers, sex hormone concentrations and gonadal and thyroid tissue measures in tilapia.Animal study. Ismail RF et al., 2023 (Frontiers in Physiology). PMID 37637141 ↗
These are the studies our verdict leans on, chosen from the 6,389 we read for Lycopene. The full linked list is below.
The studies, linked.
12 sources behind our Lycopene verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEffect of Different Doses of Tomato Lycopene on the Blood Pressure in Prehypertensives and Grade I Never Treated Otherwise Healthy SubjectsClinicalTrials.gov ↗NA · 130 participants · Terminated
- Clinical trialA Randomized, Double-Blind, Placebo-Controlled Trial Evaluating The Safety And Efficacy Of An Oral Supplement Containing Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin AgingClinicalTrials.gov ↗NA · 100 participants · Completed
- Clinical trialNovel Anti-inflammatory Dietary Intervention to Improve the Metabolic Phenotype of Overweight and Obese 13-18 Year Old Adolescents - Insights Into Potential Genetic SusceptibilityClinicalTrials.gov ↗NA · 58 participants · Completed
- Clinical trialA Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA ElevationClinicalTrials.gov ↗PHASE2 · 47 participants · Completed
- ClinicalTrials.gov ↗
- Clinical trialComparative Study of the Efficacy of Lycopene Versus Prednisolone in the Management of Oral Lichen Planus: A Randomized, Double Blind Clinical TrialClinicalTrials.gov ↗PHASE4 · 28 participants · Completed
- Clinical trialExamining Associations Between Fruit and Vegetable Intake, Skin Carotenoids, and Inflammation Among Racially and Ethnically Diverse ParticipantsClinicalTrials.gov ↗NA · 27 participants · Completed
- Clinical trialThe Influence of Tomato Soy Juice on Inflammation in Overweight and Obese AdultsClinicalTrials.gov ↗NA · 19 participants · Terminated
- Clinical trialPhase I Multiple Dose Pharmacokinetic Study of Lycopene Delivered in a Well-Defined Food-Based Lycopene Delivery System (Tomato Paste-Oil Mixture) in Patients at Increased Risk for Developing Prostate CancerClinicalTrials.gov ↗PHASE1 · 18 participants · Completed
- Clinical trialShort-term Annatto Carotenoids Supplementation Effect on LDL Susceptibility to Ex-vivo Oxidation and Oxidative Stress Biomarkers in Healthy IndividualsClinicalTrials.gov ↗NA · 16 participants · Completed
- Clinical trialThe Impact of Antioxidants on MRI Markers of Cell Proliferation and Hypoxia Among Men on Active Surveillance With Early Stage Prostate CancerClinicalTrials.gov ↗PHASE2 · 16 participants · Completed
- Clinical trialSafety and Efficacy of an Antioxidant Based Dietary Supplement With PUFAs in Healthy Female Volunteers With Cellulite (Orange Peel Skin)ClinicalTrials.gov ↗NA · 8 participants · Terminated
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 1,750 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Lycopene is, not how risky it is. A report is not proof Lycopene caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.





